AGLE Aeglea BioTherapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Pegzilarginase for the Treatment of Arginase 1 Deficiency$Aeglea生物制药(AGLE)$
发布于: | Android | 转发:0 | 回复:0 | 喜欢:0 |
AGLE Aeglea BioTherapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Pegzilarginase for the Treatment of Arginase 1 Deficiency$Aeglea生物制药(AGLE)$